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Abstract 
Background:  Information on the impact of annual community-directed treatment with ivermectin (CDTI) on the 
prevalence and intensity of onchocerciasis as well as its transmission following years of repeated ivermectin 
distribution is vital to monitor the impact of the control efforts.  
Objective:  To determine the status of the prevalence and intensity of onchocerciasis after four years of ivermectin 
distribution   in Teppi area.     
Methods:  Skin snips were obtained from 390 study participants and kept in physiological saline at room temperature 
for 24 hours. The emerged microfilariae were counted under 10x microscope objective. The skin snips were weighed 
and the microfilarial load was expressed as the arithmetic mean of two skin snips per mg of skin snip.  
Results:  Out of the total 390 examined subjects, 87 (22.3%) were found to be positive for microfilaridermia.  
Significant differences in the prevalence and microfilarial load of the disease were not found among untreated and 
treated subjects (p > 0.05). Significant reductions of the prevalence (25.5%)  and intensity of   infection (0.08 – 8mf,  
mean 1.3) were found compared to prevalence (81%) and intensity of infection ( 0-855,  mean 33 ± 5.6) reported 
before the initiation of the CDTI programme in the study area.  
Conclusion: The overall results of the study showed a high reduction both in the prevalence and intensity of infection 
compared to prevalence and intensity of the disease before the initiation of the CDTI programme in the study area.  
Nevertheless, continued assessment of the long-term impact of repeated annual CDTI programme on onchocerciasis 
and identification of factors that could affect the sustainability of the programme in various CDTI areas of Ethiopia,    
could contribute towards the effective control of the programme. [Ethiop. J. Health Dev.  2010;24(1):51-56] 
   
Introduction 
Onchocerciasis is a disease of public health and socio-
economic concern in many African countries. The 
ultimate goal of the African Programme for 
Onchocerciasis Control (APOC) is to reduce the public 
health and socio-economic problems of onchocerciasis 
within a period of 12-15 years using the strategy of 
yearly community-directed treatment with ivermectin 
(CDTI) in endemic areas. Ivermectin is highly 
appreciated for its effectiveness in the mass treatment of 
onchocerciasis (1).  However, it is important to assess the 
impact of annual CDTI on the prevalence/transmission of 
onchocerciasis and community microfilarial load (CMFL) 
following years of repeated annual ivermectin 
distribution in order to monitor the direction of the 
control efforts (2-4). 
 
In Ethiopia, onchocerciasis has been known to be 
endemic in several localities of the Southwestern and 
Northwestern parts in different magnitudes of endemicity 
(5-8). A countrywide Rapid Epidemiological Mapping of 
Onchocerciasis (REMO) carried out in 1997 and 2001 by 
APOC in collaboration with the Ethiopian Federal 
Ministry of Health revealed that onchocerciasis was 
much more widespread in Ethiopia than previously 
estimated (9). Based on the REMO results of 1997, a 
community-based  free distribution of ivermectin  was 
first launched  in Sheka Zone, Southwestern Ethiopia in  
the year 2001 and then in the rest of endemic regions 
phase by phase (10). 
 
Prior to the initiation of CDTI programme in Teppi area,   
Mengistu et al. (11) studied the prevalence and intensity 
of  onchocerciasis  in  residents  of  Endris-Goji and 
Addis Berhane villages.  In this study, they reported a 
prevalence of  81%  and a  microfilarial load   ranging 
from 0-855 (mean 33 ± 5.6) in the age group 11-78 years. 
Although the CDTI programme is in its 4th year of 
implementation period in Teppi area, there is no report 
on the impact of annual CDTI on the magnitude of 
onchocerciasis after the implementation of the 
programme in the area.  Therefore, the aim of this study 
was to determine the status of the prevalence and 
intensity of onchocerciasis after four years of  ivermectin 
distribution  using  the pre-intervention  information on 
the prevalence  and  intensity of the disease in  same 
study area.  
 
Methods 
Study Area and Population 
In February 2005, a cross-sectional parasitological survey 
was conducted in three adjacent villages (Endris-Goji, 
Addis Berhane and Nupa) around Teppi town, to assess 
the prevalence and intensity of onchocerciasis after four 
years of ivermectin distribution.  The villages are found 
630 km to the Southwest of Addis Ababa and about 8 km 
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to the Southeast of Teppi town. The majority of 
inhabitants of Endris-Goji were the indigenous 
Mezhenger ethnic group, while the inhabitants of Addis 
Brehane and Nupa were  a mixture of Amahara and Kafa 
ethnic group who came to the area from other parts of 
Ethiopia.   Most of the inhabitants were engaged in 
mixed farming, coffee plantation, maize cultivation and 
rearing livestock. According to information obtained from 
the leader of the villages, there were about 673 
households with a total of approximately 4365 population 
in the three villages. The inhabitants of the villages were 
living under similar setting. A more detailed description 
of the study area are given elsewhere (11). 
       
In the study villages, community based ivermectin 
(Mectizan®) treatment for onchocerciasis was initiated in 
October 2001. However, during the second round of the 
treatment it was delayed for five months because of the 
month of October is the harvest time in the area. The 
second round ivermectin distribution was performed in 
March 2002 and then annually distributed to all eligible 
members of the communities in the villages through 
community drug distributors using the height and 
physical appearance dosing method (12). This survey 
was conducted one month prior to the fifth round of 
annual ivermectin distribution in the area. According to 
the information obtained from community drug 
distributors and District Health Office, the annual 
treatment coverage of ivermectin was high (over 90%) 
and sustainable in the study area. Adults and children 
(age over 5 years) who lived in the area for more than 
one year, ivermectin treated or untreated, but volunteered 
to participate were included in the study. 
 
Sample Size Estimation 
Pre-intervention information on the prevalence of 
onchocerciasis (81%) in the study villages (11) was used 
as background information to estimate the sample size.  
However, since the CDTI programme was in its 4th 
annual round in the study area during the survey, a 20% 
reduction in the prevalence of the disease due to the 
effect of the intervention was assumed (13). Hence, a 
total of 388 (after adding 5% compensation for reluctant 
cases) study participants were considered to be included 
in the study. 
 
Sample Collection   and Examination 
After explaining the aim of the study and obtaining 
informed consent from the leaders of the villages, the 
total number of households in the study villages was 
estimated. Then, house-to-house visit was made to 
inform randomly selected (random selection was done 
using the lists of households)  head of the households to 
come to a central place with their eligible families (both 
male and female, older than 5 years) for onchocerciasis 
examination. Then, two skin snips, one from the left and 
the other from the right iliac crest were taken from each 
study participants  under aseptic condition  using 
disposable sterile pricking needle and razor blade. The 
skin snips were then separately placed in flat-bottomed 
micro-titer plate wells filled with 100 µl of physiological 
saline and left at room temperature for 24 hours.  About 
four drops of 4% formalin were added into each well and 
the samples were transported to laboratory as previously 
described (7, 8, 11).  The skin snip from each well was 
collected onto a filter paper and the whole content in 
individual well was transferred onto a microscopic slide. 
The emerged microfilariae were counted under 10x 
microscope objective. The skin snips from each subject 
were weighed using analytical balance (Mettler AE 260 
Delta Range) after avoiding excess water by tapping on 
absorbent   filter paper. The microfilarial load of each 
positive subject was calculated as the arithmetic mean of 
two skin snips per mg of skin snip (8, 11). The CMFL 
was calculated only for those study participants who 
were 20 years and older as previously recommended (14). 
Pre-intervention information on the prevalence and 
intensity of onchocerciasis (11) was used as background 
information to assess the impact of ongoing CDTI 
programme on the prevalence of the disease. Information 
on age, gender as well as history of treatment with 
ivermectin were collected during the survey. 
 
Data Analysis 
The percentage of individuals with onchocerciasis was 
determined by dividing the total number of positive 
individuals for O. volvulus infection by the total number 
of study participants. Chi-square (X2) test was used to 
compare the proportion of infection among the different 
categories of the study subjects. Arithmetic mean was 
used to determine the intensity of infections.  Student t-
test was also used to compare the means of microfilarial 
load between the different study groups. Differences 
were considered to be significant when p value less than 
0.05. 
 
Ethical Consideration  
The study was ethically approved by the Ethical 
Clearance Committee of Aklilu Lemma Institute of 
Pathobiology, Addis Ababa University. The objective of 
the study was explained to the participants or their 
guardians in local language. Skin snip samples were 
taken after informed verbal consent was obtained. 
Positive individuals for onchocerciasis were advised to 
receive ivermectin treatment during the scheduled 
distribution. Negative individuals were also advised to 
continue receiving the regular annual treatment.    
 
Results 
A total of 390 study participants (202 females and 188 
males) in the age range of 5-85 years (mean 21.7) 
volunteered to provide skin snips. The socio-
demographic characteristic of the study participants is 
shown in Table 1. Out of 390 examined subjects, 87 
(22.3%) were found positive for microfilaridermia. 
Significant differences in the prevalence of the disease 
were not found between males and females or among 
different age groups (p > 0. 05) (Table 2).  However, the 
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prevalence of the disease was found to be significantly 
higher in the study participants from Endris-Goji village 
compared to study subjects from Addis Berhane (p < 
0.001) and Nupa (p < 0.05) villages.  The prevalence of 
the disease was also found to be significantly higher in 
the study participants who lived over 10 years in the area 
(p < 0.05). The overall microfilarial load of the positive 
individuals ranged from 0.08 – 8mf (mean 1.2) per gm of 
skin snip.  Table 3 shows the status of treatment with 
ivermectin versus prevalence of onchocerciasis and 
microfilarial load of the study participants positive for 
microfilaridermia. 
 
Table 1:   Socio-demographic characteristics of the study 
participants, Teppi area, Southwestern Ethiopia, February 
2005 
Variable  Number(%) 
Gender  of participants   
     Male 188 (48.2) 
     Female 202 (51.8) 
Age group (year)   
     5 – 14 166 (42.6) 
    15 – 24 74  (19.0) 
    25 – 34 71 (18.2) 
    35 + 79 (20.2) 
Ethnic Group  
     Mesjenger 163 (41.8) 
     Amahra 126 (32.3) 
     Kafa 91 (23.3) 
     Other 10 (2.6) 
Village   
     Endris-Goji 141 (36.2) 
     Addis Berhane 157 (40.2) 
     Nupa 92 (23.6) 
Length of residence  (year)  
    1-9 102 (26.2) 
    10-19 123 (31.5) 
     20+ 165 (42.3) 
Significant differences in the prevalence of 
onchocerciasis were not found among the percentages of 
the untreated, less than four round treated and four round 
treated groups (p > 0.05). Similarly, the microfilarial load 
did not significantly differ among the groups. The overall 
CMFL for 192 study participants (including those with 
negative counts) who were 20 years and older ranged 
from 0 - 8 mf (mean 0.38) per mg of skin snip.  However, 
the CMFL for those 48 positive subjects (age over 20 
years) ranged from 0.08-8 mf (mean 1.5) per mg of skin 
snip. 
 
Table 2:  Prevalence of onchocerciasis according 
gender, age, village and length of residence, Teppi 
area, Southwestern Ethiopia, February 2005     
         Variable  Number Positive 
(%) 
Gender    
     Male 46 (24.5) 
     Female 41 (20.3) 
Age group (year)   
     5 - 14 31 (18.7) 
    15 - 24 19 (25.7) 
    25 - 34 18 (25.4) 
    35 + 19 (24.1) 
Village   
    Endris-Goji  46 (32.6)* 
    Addis Berhane 23 (14.6)* 
    Nupa 18 (19.6)* 
Length of residence  (year)  
    1-9 14 (13.7)* 
    10-19 31 (25.2) 
    20+ 42 (25.5)* 
* Significant difference 
 
Table 3:  Prevalence of onchocerciasis and microfilarial load in all the study participants,  




 subjects  
Age range  
(mean)  
Number Positive (%) MFL range (mean)/mg of  
skin  
Untreated  24  5-35 (11.1) 4 (16.7%) 0.25-1.7 (0.83) 
1st   round  44 6-70 (12.7) 13 (29.5%) 0.13-5.5 (1.7) 
2nd   round  76 7-55 (14.1) 16 (21.1%) 0.18-7.8 (1.5) 
3rd  round  68 8-85 (20.3) 15 (22.1%) 0.11-2.5 (0.69) 
4th  round  178 8-70 (29.3) 39 (21.9%) 0.08-8 (1.2) 
 
Previous study conducted in the same villages before the 
initiation of the CDTI programme involved individuals in 
the age group 11-78 years. In order to compare the  
present  prevalence and intensity of onchocerciasis with 
the baseline prevalence and intensity, individuals 
younger than 10 years were excluded, and data was 
analyzed for 271 (134 males and 137 females , age rang 
10-85, mean 28.0 years) participants. Of these, 69 (25.5%) 
individuals were found positive for microfilaridermia. 
The overall microfilarial load of the positive individuals 
ranged from 0.08 – 8mf (mean 1.3) per gm of skin snip. 
The present prevalence (25.5%) and intensity of infection 
are significantly lower than prevalence (81%) and 
intensity of infection (0- 855, mean 33 ± 5.6) reported 
before the initiation of the CDTI programme in the study 
area.  Table 4 shows the status of treatment with 
ivermectin versus prevalence of onchocerciasis and 
microfilarial load of the study participants whose age was 
over 10 years. 
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Table 4:  Prevalence of onchocerciasis and microfilarial load in study participants age 10 years and above,   




 subjects  




MFL range (mean)/mg of  
skin  
Untreated  8  13-35 (24.3) 3 (37.5%) 0.4-1.7 (1.0) 
1st   round  9 20-70 (34.3) 6 (66.7%) 0.25-5.5 (2.1) 
2nd   round  35 11-55 (21.1) 9 (25.7%) 0.18-7.8 (1.8) 
3rd  round  53 11-85 (23.7) 11 (20.8%) 0.11-2.5 (0.84) 
4th  round  166 11-70 (30.7) 39 (23.5%) 0.08-8 (1.2) 
 
Discussion 
In this study pre-intervention information on the 
prevalence and intensity of onchocerciasis  (11) was used 
as background information to assess the impact of 
ongoing CDTI programme on onchocerciasis in untreated 
and subjects at various rounds of treatment in an area 
where the fourth round of annual CDTI was completed. 
The overall results showed a marked reduction in both 
the prevalence (22.3%) and the intensity of infection (0-8 
mf/gm of skin snip, mean 1.2) compared to the 
prevalence (81%) and intensity (0-855, mf/gm of skin 
snip, mean 33) of infection reported prior to the initiation 
of CDTI programme in the study area (11). One major 
difference between the present and the previous study 
was that the present study included individuals in the age 
range 5-85 years, while the previous one considered 
individuals’ age ranging from 11- 78 years. Nevertheless, 
the observed high reduction rate in the prevalence and 
intensity of infection remained high even when 
individuals younger than 10 years were excluded from 
data analysis. The findings of the present study also 
corroborated the findings of others that repeated 
ivermectin treatments can result in a profound reduction 
in the transmission/prevalence of onchocerciasis as well 
as in the intensity of infection even in the areas where 
vector control activities have not been conducted (2, 15-
18). 
 
Our study also showed that relatively a higher prevalence 
of onchocerciasis among study participants from Endris-
Goji  village than  from the other villages, which is in 
agreement with the result of previous study conducted in  
the area  (11).  This might possibly be attributed to their 
life style that the Mezhengers are hunters, honey 
collectors, activities which increase exposure and re-
exposure to fly bites and could lead to super infection 
(19).  It could also be explained by a longer duration of 
exposure to the disease by native inhabitants as 
evidenced in the present study.   
 
Studies in Burundi (20) and Cameroon (13) have shown a 
high reduction in the prevalence and the intensity of 
microfilaridermia in young children who have never 
received ivermectin, but lived in four annual rounds of 
mass ivermectin treated communities. In agreement with 
these previous findings, we found absence of significant 
differences in the prevalence of onchocerciasis among 
the untreated and four round treated study participants. A 
significant reduction in microfilarial load was observed 
following four rounds of repeated annual treatments of 
onchocerciasis with ivermectin in six of the 10 
communities studied in Nigeria (4). Contrary to this 
finding, the present study revealed absence of significant 
difference in microfilarial load among untreated, less 
than four round treated and four round treated study 
participants. Further study involving large sample size 
may be needed to investigate the discrepancy between 
the present and this previous study. 
 
The present study indicated that the on-going mass 
ivermectin treatment has been effective in reducing the 
prevalence of onchocerciasis though its long-term impact 
and success in eradication of the disease needs to be 
followed. As  parasitological assessment in human host 
alone cannot confirm the impact of mass  ivermectin  
treatment on the transmission of onchocerciasis, the 
impact of CDTI on parasite  in the blackfly vector need 
to be assessed  even if method of data collection and  
interpretation of results  are difficult  as the transmission 
potentials may vary from year to year  and the larvae of 
O.volvulus closely resemble those of O.ochengi, a 
parasite of cattle transmitted by blackflies of the same 
species (21,22). 
 
The success of the CDTI progrmme can be affected   by 
factors such as   the level of community awareness about 
the cause, mode of transmission and preventive methods 
of the disease, inadequate and poor community 
mobilization, village characteristics, system of drug 
distribution, conflict among different ethnic groups and 
the motivation of community drug distributors (CDDs) 
(23-27).  Hence, assessment of community perception 
about the disease and the CDTI program, and timely 
report on community response to the programme could 
help to manage and sustain the annually ivermectin 
distribution activity in the study area. 
 
In conclusion, the results of the present study showed a 
considerable reduction both in the prevalence and 
intensity of onchocerciasis  in the study area,  after four 
years of annual CDTI compared to the prevalence and 
intensity of infection of the disease prior to the initiation 
of CDTI programme. Since no other control measures 
have been implemented in the study area, the present 
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observed reduction in prevalence as well as intensity of 
infection can be attributed to the consecutive ivermectin 
distribution and high treatment coverage. Nevertheless, 
continued assessment of the long-term impact of repeated 
annual CDTI programme on onchocerciasis and 
identification of factors that could affect the 
sustainability of the programme in various CDTI areas of 
Ethiopia, could contribute towards the effective control 
of the programme. 
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